ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,310.03
-0.81%
S&P 500
5,469.30
0.39%
Dow Jones
39,112.16
-0.76%
US Dollar vs Yen
160.0315
0.21%
Brent Oil
84.945
0.90%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Vallon Pharmaceuticals Inc (VLON)

  7. Vallon Pharmaceuticals Inc (VLON) ニュース

VLON

Vallon Pharmaceuticals (VLON)

Vallon Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VLON
日付受信時刻ニュースソース見出しコード企業名
2024/06/1905 : 54Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/06/1905 : 52Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/06/1905 : 48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
2024/06/1421 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
2024/06/0805 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
2024/06/0104 : 34Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/06/0104 : 32Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/05/2305 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
2024/05/2105 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
2024/05/2105 : 11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/05/1713 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VLONVallon Pharmaceuticals Inc
2024/05/1713 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VLONVallon Pharmaceuticals Inc
2024/05/1505 : 46Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/05/1505 : 44Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/05/1321 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
2024/05/1106 : 24Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VLONVallon Pharmaceuticals Inc
2024/05/1105 : 53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/05/1005 : 31Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VLONVallon Pharmaceuticals Inc
2024/04/0122 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
2024/03/2905 : 45Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/03/2905 : 42Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/02/0306 : 25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/02/0306 : 23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
2024/02/0306 : 21Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/02/0214 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VLONVallon Pharmaceuticals Inc
2024/01/3022 : 13Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/01/3022 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
2024/01/2006 : 16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
2024/01/2006 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
2024/01/1622 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VLON

最近閲覧した銘柄

CCOM
US30
US 30
NYSE
DIS
Walt Disney
SPI
SP500
S&P 500
AMEX
SPY
SPDR S&P 500
NASDAQ
NVDA
NVIDIA
NYSE
KO
Coca Cola
NASDAQ
TSLA
Tesla
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
NYSE
AXP
American Express
NYSE
VZ
Verizon Communications
NASDAQ
AMZN
Amazon.com
CCOM
US100
US Tech 100
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有